StreetAlpha.app
Home › Stocks › BWAY

Brainsway Ltd. (BWAY)

$9.11
▼ −2.98%
LAST CLOSE · NOV 17

BrainsWay makes Deep TMS magnetic brain stimulation systems used to treat mental health disorders. It last closed at $9.11 on Nov 17, down 2.98% on the day.

AI Auto Pilots
Is BWAY in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$46.1M
Net income
$5.3M
11.6% margin
Gross margin
74.5%
$34.3M gross profit
Operating margin
4.0%
$1.9M operating income
Balance sheet
Cash & equivalents
$67.9M
At Jun 30
Shareholder equity
$68.1M
ExchangeNasdaq
Financials history
FY2020: $22.1M$22.1MFY2020FY2021: $29.7M$29.7MFY2021FY2022: $27.2M$27.2MFY2022FY2023: $31.8M$31.8MFY2023FY2024: $41.0M$41.0MFY2024

From BWAY's SEC filings, latest 20-F for the period ending Jun 30, 2025 (filed Apr 20). Last 12 months adds up the four latest quarters. Per share figures are left out because the US listing can represent a different number of shares.

Next report
—
No date on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated BWAY in the past 90 days, not enough for a consensus
Average 12-month target
$19.00
▲ 108.6% upside

Based on 1 analyst who set a price target on BWAY in the past 90 days. The average target is $19.00, with a high of $19.00 and a low of $19.00, compared with the last close of $9.11.

Low $19.00Avg $19.00High $19.00
Blue marker: last close $9.11
Highest target$19.00
Average target$19.00
Lowest target$19.00
Latest rating changes
HC Wainwright & Co.Target raised
Aug 31Buy$17 → $19
Ladenburg ThalmannMaintained
Aug 13Buy$18.80
BTIGTarget raised
Aug 12Buy$18 → $20
BTIGInitiated
Jul 20Buy$18
HC Wainwright & Co.Reiterated
Jul 2Buy$17
DateFirmActionRatingPrice target
Aug 31HC Wainwright & Co.Target raisedBuy$17 → $19
Aug 13Ladenburg ThalmannMaintainedBuy$18.80
Aug 12BTIGTarget raisedBuy$18 → $20
Jul 20BTIGInitiatedBuy$18
Jul 2HC Wainwright & Co.ReiteratedBuy$17
Loading…

Technical Analysis

BWAY · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold

The stock is 21% below its 20 day and 32% below its 50 day average. It is 52% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 31), near oversold. The nearest support is the Pivot S1 at $8.91, and the nearest resistance the Pivot at $9.17.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 7.3%/day
Key levels
$17.4052 week high+91.0%
$13.85200 day average+52.0%
$13.62100 day average+49.5%
$12.0650 day average+32.4%
$12.05Swing high (Oct 29)+32.3%
$10.9920 day average+20.6%
$9.37Pivot R1+2.9%
$9.17Pivot+0.7%
$9.11Last close
$8.91Pivot S1−2.2%
$7.1452 week low−21.6%
Indicators
RSI (14)31.42Weak, oversold below 30Neutral
MACD-0.65Below its signal lineBearish
Stochastic7.6Near the bottom of its rangeOversold
ADX (14)20.4Weak trend
Williams %R-95.6Oversold below −80, overbought above −20Oversold
CCI (20)-225.7Oversold below −100, overbought above 100Oversold
Rate of change−18.3%Change over 10 sessionsBearish
ATR (14)$0.67Typical daily range, 7.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for BWAY

What happened before

See how BWAY did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow BWAY usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How BWAY has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in BWAY in the last 90 days.

Loading…

See today’s whale options flow across the market →

BWAY Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●29 buying vs 27 selling
  • ●Shares held by funds -0.9%
  • ▲Funds holding +9
  • ▼Superinvestors: 1 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding6556+16.1%
In funds' top 10110.0%
Held by funds–––
New / increased18 / 118 / 16+20.8%
Reduced / sold out18 / 918 / 8+3.8%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See BWAY institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BWAY is in one of them and how their past BWAY trades turned out.

BWAY in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered BWAY in an article yet. Here's the latest on the wider market.

About Brainsway

BrainsWay is a medical technology company based in Jerusalem, Israel. It makes Deep TMS systems, which use magnetic pulses to stimulate brain regions in a noninvasive way to treat mental health conditions. The treatments are cleared in the United States for depression, including anxious depression, and obsessive-compulsive disorder, and the company markets them for smoking addiction. It sells its systems to psychiatrists' offices and other treatment facilities that care for these patients.

Headquarters
Jerusalem, Israel
Founded
2003